(HII) Huntington Ingalls - Ratings and Ratios
Warships, Submarines, Carriers, Nuclear Support, C5ISR
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.32% |
| Yield on Cost 5y | 3.86% |
| Yield CAGR 5y | 4.23% |
| Payout Consistency | 100.0% |
| Payout Ratio | 37.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 37.1% |
| Value at Risk 5%th | 47.1% |
| Relative Tail Risk | -22.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.08 |
| Alpha | 102.43 |
| CAGR/Max DD | 0.60 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.355 |
| Beta | 0.593 |
| Beta Downside | 0.640 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.21% |
| Mean DD | 11.28% |
| Median DD | 7.34% |
Description: HII Huntington Ingalls January 04, 2026
Huntington Ingalls Industries (HII) is the U.S. Navy’s primary shipbuilder, designing, constructing, overhauling, and repairing both non-nuclear (amphibious assault ships, surface combatants, Coast Guard cutters) and nuclear-powered platforms (aircraft carriers, submarines). The firm operates through three segments-Ingalls, Newport News, and Mission Technologies-and also supplies C5ISR, AI-driven decision tools, cyber-electronic warfare, and autonomous systems to support fleet sustainment.
Key quantitative drivers: (1) Backlog ≈ $41 billion at FY 2024 end, providing multi-year revenue visibility; (2) Free-cash-flow conversion ≈ 45% of operating cash, underpinning dividend sustainability; (3) U.S. defense spending outlook-annual FY 2025 defense budget projected to rise ~3% YoY, with the Navy earmarking >$15 billion for new ship construction, directly feeding HII’s order pipeline. Sensitivity to federal budget cycles and ship-yard labor constraints remains a material risk.
For a deeper dive into HII’s valuation dynamics and scenario modeling, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 569.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.75 > 1.0 |
| NWC/Revenue: 3.13% < 20% (prev -6.04%; Δ 9.17% < -1%) |
| CFO/TA 0.08 > 3% & CFO 937.0m > Net Income 569.0m |
| Net Debt (2.61b) to EBITDA (1.14b): 2.29 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.4m) vs 12m ago -0.25% < -2% |
| Gross Margin: 12.52% > 18% (prev 0.14%; Δ 1238 % > 0.5%) |
| Asset Turnover: 102.7% > 50% (prev 105.6%; Δ -2.94% > 0%) |
| Interest Coverage Ratio: 7.70 > 6 (EBITDA TTM 1.14b / Interest Expense TTM 106.0m) |
Altman Z'' 2.86
| A: 0.03 (Total Current Assets 3.08b - Total Current Liabilities 2.70b) / Total Assets 12.31b |
| B: 0.44 (Retained Earnings 5.38b / Total Assets 12.31b) |
| C: 0.07 (EBIT TTM 816.0m / Avg Total Assets 11.70b) |
| D: 0.73 (Book Value of Equity 5.36b / Total Liabilities 7.33b) |
| Altman-Z'' Score: 2.86 = A |
Beneish M -2.92
| DSRI: 1.04 (Receivables 2.47b/2.32b, Revenue 12.01b/11.71b) |
| GMI: 1.11 (GM 12.52% / 13.84%) |
| AQI: 1.00 (AQ_t 0.43 / AQ_t-1 0.43) |
| SGI: 1.03 (Revenue 12.01b / 11.71b) |
| TATA: -0.03 (NI 569.0m - CFO 937.0m) / TA 12.31b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
ValueRay F-Score (Strict, 0-100) 60.22
| 1. Piotroski: 4.50pt |
| 2. FCF Yield: 4.27% |
| 3. FCF Margin: 6.85% |
| 4. Debt/Equity: 0.59 |
| 5. Debt/Ebitda: 2.29 |
| 6. ROIC - WACC: 0.48% |
| 7. RoE: 11.79% |
| 8. Revenue Trend: 72.71% |
| 9. EPS Trend: -38.73% |
What is the price of HII shares?
Over the past week, the price has changed by +1.73%, over one month by +22.29%, over three months by +40.76% and over the past year by +113.16%.
Is HII a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 380.6 | -10% |
| Analysts Target Price | 380.6 | -10% |
| ValueRay Target Price | 535.2 | 26.6% |
HII Fundamental Data Overview January 24, 2026
P/E Forward = 23.31
P/S = 1.3856
P/B = 3.328
P/EG = 1.3179
Revenue TTM = 12.01b USD
EBIT TTM = 816.0m USD
EBITDA TTM = 1.14b USD
Long Term Debt = 2.70b USD (from longTermDebt, last quarter)
Short Term Debt = 503.0m USD (from shortTermDebt, last fiscal year)
Debt = 2.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.61b USD (from netDebt column, last quarter)
Enterprise Value = 19.26b USD (16.64b + Debt 2.93b - CCE 312.0m)
Interest Coverage Ratio = 7.70 (Ebit TTM 816.0m / Interest Expense TTM 106.0m)
EV/FCF = 23.40x (Enterprise Value 19.26b / FCF TTM 823.0m)
FCF Yield = 4.27% (FCF TTM 823.0m / Enterprise Value 19.26b)
FCF Margin = 6.85% (FCF TTM 823.0m / Revenue TTM 12.01b)
Net Margin = 4.74% (Net Income TTM 569.0m / Revenue TTM 12.01b)
Gross Margin = 12.52% ((Revenue TTM 12.01b - Cost of Revenue TTM 10.51b) / Revenue TTM)
Gross Margin QoQ = 12.34% (prev 12.82%)
Tobins Q-Ratio = 1.56 (Enterprise Value 19.26b / Total Assets 12.31b)
Interest Expense / Debt = 0.79% (Interest Expense 23.0m / Debt 2.93b)
Taxrate = 28.92% (59.0m / 204.0m)
NOPAT = 580.0m (EBIT 816.0m * (1 - 28.92%))
Current Ratio = 1.14 (Total Current Assets 3.08b / Total Current Liabilities 2.70b)
Debt / Equity = 0.59 (Debt 2.93b / totalStockholderEquity, last quarter 4.98b)
Debt / EBITDA = 2.29 (Net Debt 2.61b / EBITDA 1.14b)
Debt / FCF = 3.18 (Net Debt 2.61b / FCF TTM 823.0m)
Total Stockholder Equity = 4.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.87% (Net Income 569.0m / Total Assets 12.31b)
RoE = 11.79% (Net Income TTM 569.0m / Total Stockholder Equity 4.83b)
RoCE = 10.84% (EBIT 816.0m / Capital Employed (Equity 4.83b + L.T.Debt 2.70b))
RoIC = 7.46% (NOPAT 580.0m / Invested Capital 7.78b)
WACC = 6.97% (E(16.64b)/V(19.57b) * Re(8.10%) + D(2.93b)/V(19.57b) * Rd(0.79%) * (1-Tc(0.29)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF Debug] Terminal Value 82.38% ; FCFF base≈668.2m ; Y1≈688.9m ; Y5≈775.3m
Fair Price DCF = 366.0 (EV 16.98b - Net Debt 2.61b = Equity 14.36b / Shares 39.2m; r=6.97% [WACC]; 5y FCF grow 3.14% → 2.90% )
EPS Correlation: -38.73 | EPS CAGR: -46.92% | SUE: -3.50 | # QB: 0
Revenue Correlation: 72.71 | Revenue CAGR: 4.80% | SUE: 1.51 | # QB: 2
EPS next Quarter (2026-03-31): EPS=3.94 | Chg30d=+0.046 | Revisions Net=+0 | Analysts=5
EPS next Year (2026-12-31): EPS=17.65 | Chg30d=+0.165 | Revisions Net=+6 | Growth EPS=+16.1% | Growth Revenue=+5.5%
Additional Sources for HII Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle